FDA approves single-injection, bolus-dose thrombolytic agent.
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D000077785:Tenecteplase; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase